ImExHS Limited (IME)

IMEXHS Limited Investor Q&A for Appendix 4C Announcement and Summary of Activities

01 August 2019 - Managing Director & CEO: German Arango

You may also be interested in...

View all

Other Open Briefings in the Health Care Sector

22 May 2025
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Full Year Results Analyst Briefing
27 Mar 2025
Healius Limited (HLS)
Healius Investor Day
03 Mar 2025
Pacific Smiles Group Limited (PSQ)
Pacific Smiles Group Half Year Results Briefing
27 Feb 2025
Monash IVF Group Limited (MVF)
Monash IVF Group Limited FY25 Half Year Results announcement
20 Feb 2025
Healius Limited (HLS)
Healius 1H25 Results
21 Nov 2024
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Half Year Results Analyst Briefing
23 Sep 2024
Healius Limited (HLS)
Sale of Lumus Imaging
18 Sep 2024
Clarity Pharmaceuticals Ltd (CU6)
Investor Update
28 Aug 2024
Ecofibre Limited (EOF)
EOF FY24 Results
28 Aug 2024
SomnoMed Limited (SOM)
FY24 Results

Email this page

Subscribe to company

Latest Open Briefings

01 Sep 2023
IMEXHS HY23 Results Presentation
01 Mar 2023
IMEXHS FY22 Results Presentation
30 Aug 2022
IMEXHS Limited 1H FY22 Conference Call
01 Mar 2022
IMEXHS Limited FY21 Conference Call
30 Aug 2021
IMEXHS Limited 1H FY21 Conference Call

Load next 5 items

Contact MUFG Corporate Markets for further information about Open BriefingAdvertiseCopyrightDisclaimer©2025 MUFG Corporate Markets IR Pty Ltd
events@cm.mpms.mufg.com +61 2 8280 6000 www.mpms.mufg.com/en/mufg-corporate-markets/au/services/investor-relations